Invesco Perpetual
Investor profile
Investment firm
Invesco Perpetual has backed 4 European tech companies across 5 funding rounds between 2010 and 2018, joining rounds totalling €149M. Most active in Healthtech and Software. Data as of 4 Nov 2026.
Deals
5
distinct rounds
Companies
4
backed
Active span
2010–2018
9 yrs
Total round €
€149M
sum of rounds joined
Deals by year
distinct rounds / yearInvesco Perpetual — deals by year — interactive chart.
Data table
| Invesco Perpetual — deals by year | |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
Top sectors
by dealsInvesco Perpetual — top sectors — interactive chart.
Data table
| Invesco Perpetual — top sectors | |
|---|---|
| Healthtech | 4 |
| Software | 1 |
Stages
by dealsInvesco Perpetual — stages — interactive chart.
Data table
| Invesco Perpetual — stages | |
|---|---|
| Series B | 2 |
| Series C | 1 |
| Series D+ | 1 |
| Other | 1 |
Countries
by dealsInvesco Perpetual — countries — interactive chart.
Data table
| Invesco Perpetual — countries | |
|---|---|
| UK | 5 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Cell Medica | UK | 1 | €64M |
| Oxford Nanopore Technologies | UK | 2 | €49M |
| Genomics | UK | 1 | €28M |
| Oxford Genetics | UK | 1 | €8.1M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Cell Medica | Series B | €64M | 2014-11 |
| Oxford Nanopore Technologies | Series D+ | €28M | 2011-04 |
| Genomics | Series B | €28M | 2018-09 |
| Oxford Nanopore Technologies | Series C | €21M | 2010-04 |
| Oxford Genetics | Other | €8.1M | 2017-08 |